FDA moves to reverse regulatory blunder on hip implants


Ten or so years ago, companies were able to start selling all-metal hip (MoM) replacement products without first conducting clinical trials. The result was a disaster. There was a high failure rate for the all-metal versions, and their use plummeted. J&J has already spent some $900 million to fight and settle suits since recalling one of its MoM products, according to the Wall Street Journal.

The Federal Drug Administration (FDA) now wants to plug the loophole in the regulations that allowed the MoM debacle to happen. The result may be a complete end to the use of all-metal hip replacements, at least for the near-term future. ...
Read more